You are not signed in. Sign In  
Menlo Park - FDA, A Barrier to Innovation or a Protector of Public Health - or Both?
Speakers include: Anna Longwell, Esq., founder of Longwell & Associates, which specializes in Food and Drug Law, Robert Longwell, CFO/Treasurer of Longwell & Associates, and Nancy E. Isaac, senior counsel at Longwell & Associates.

Cost: $10
Registration Required: Click Here to Register

FDA approval is the lifeline for life sciences companies engaged in drug development, biologics, diagnostics, medical devices and combination products. Any hiccups in FDA regulatory affairs can send stocks soaring, diving or heading for bankruptcy. Come and learn about new FDA guidelines and how they impact the life sciences industry. Anna Longwell will discuss impacts on drugs, combination and ANDA (Abbreviated New Drug Application) products. Nancy Isaac will discuss the impact on medical devices, and Robert Longwell will cover changes in FDA inspections.

6:30 - 7:00 p.m. - Registration and networking
7:00 - 8:00 p.m. - Seminar
8:30 - 8:30 p.m. - Networking

Speaker Bios:
Anna Longwell, Esq. 
Robert Longwell, Esq. 
Nancy E. Isaac, Esq.
Event Contact
Lily Yang


Event Information
Wednesday, Dec 10 2014 at 6:30pm - 8:30pm [ iCal ]
Geron Corporation
149 Commonwealth Drive
Menlo Park, CA